Literature DB >> 18808527

Temporal evolution of epithelial, vascular and interstitial lung injury in an experimental model of idiopathic pulmonary fibrosis induced by butyl-hydroxytoluene.

Edwin Roger Parra1, Gabriela Boufelli, Fernanda Bertanha, Luciana de Paula Samorano, Armando Costa Aguiar, Fernanda Magalhães Arantes Costa, Vera Luiza Capelozzi, João Valente Barbas-Filho.   

Abstract

This study was undertaken to test whether the structural remodelling of pulmonary parenchyma can be sequentially altered in a model and method that demonstrate the progression of the disease and result in remodelling within the lungs that is typical of idiopathic pulmonary fibrosis. Three groups of mice were studied: (i) animals that received 3-5-di-tert-butyl-4-hydroxytoluene (BHT) and were killed after 2 weeks (early BHT = 9); (ii) animals that received BHT and were killed after 4 weeks (late BHT = 11); (iii) animals that received corn oil solution (control = 10). The mice were placed in a ventilated Plexiglas chamber with a mixture of pure humidified oxygen and compressed air. Lung histological sections underwent haematoxylin-eosin, immunohistochemistry (epithelial, endothelial and immune cells) and specific staining (collagen/elastic fibres) methods for morphometric analysis. When compared with the control group, early BHT and late BHT groups showed significant decrease of type II pneumocytes, lower vascular density in both and higher endothelial activity. CD4 was increased in late BHT compared with early and control groups, while CD8, macrophage and neutrophil cells were more prominent only in early BHT. The collagenous fibre density were significantly higher only in late BHT, whereas elastic fibre content in late BHT was lower than that in control group. We conclude that the BHT experimental model is pathologically very similar to human usual interstitial pneumonia. This feature is important in the identification of animal models of idiopathic pulmonary fibrosis that can accurately reflect the pathogenesis and progression of the human disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18808527      PMCID: PMC2613986          DOI: 10.1111/j.1365-2613.2008.00600.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  29 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Interstitial vascularity in fibrosing alveolitis.

Authors:  Elisabetta A Renzoni; David A Walsh; Michael Salmon; Athol U Wells; Piersante Sestini; Andrew G Nicholson; Srihari Veeraraghavan; Anne E Bishop; Hanna M Romanska; Panagiotis Pantelidis; Carol M Black; Roland M Du Bois
Journal:  Am J Respir Crit Care Med       Date:  2002-10-03       Impact factor: 21.405

3.  Nonhomogeneous density of CD34 and VCAM-1 alveolar capillaries in major types of idiopathic interstitial pneumonia.

Authors:  Edwin Roger Parra; Ligia Rodrigues Silvério da Costa; Alexandre Ab'Saber; Carlos Roberto Ribeiro de Carvalho; Ronaldo Adib Kairalla; Sandra Moraes Fernezlian; Lisete R Teixeira; Vera Luiza Capelozzi
Journal:  Lung       Date:  2005 Sep-Oct       Impact factor: 2.584

4.  Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis.

Authors:  G Borzone; R Moreno; R Urrea; M Meneses; M Oyarzún; C Lisboa
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

5.  Lung parenchyma remodeling in a murine model of chronic allergic inflammation.

Authors:  Debora G Xisto; Luciana L Farias; Halina C Ferreira; Miguel R Picanço; Daniel Amitrano; Jose R Lapa E Silva; Elnara M Negri; Thais Mauad; Denise Carnielli; Luiz Fernando F Silva; Vera L Capelozzi; Debora S Faffe; Walter A Zin; Patricia R M Rocco
Journal:  Am J Respir Crit Care Med       Date:  2005-01-18       Impact factor: 21.405

6.  Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).

Authors:  J V Barbas-Filho; M A Ferreira; A Sesso; R A Kairalla; C R Carvalho; V L Capelozzi
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

7.  Respiratory effects of lipopolysaccharide-induced inflammatory lung injury in mice.

Authors:  D S Faffe; V R Seidl; P S Chagas; V L Gonçalves de Moraes; V L Capelozzi; P R Rocco; W A Zin
Journal:  Eur Respir J       Date:  2000-01       Impact factor: 16.671

8.  Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.

Authors:  Edwin Roger Parra; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro de Carvalho; Esmeralda Eher; Vera Luiza Capelozzi
Journal:  Respiration       Date:  2006-11-14       Impact factor: 3.580

9.  Structural features of epithelial remodeling in usual interstitial pneumonia histologic pattern.

Authors:  Aline Lourenso Baptista; Edwin Roger Parra; João Valente Barbas Filho; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro de Carvalho; Vera Luiza Capelozzi
Journal:  Lung       Date:  2006 Jul-Aug       Impact factor: 2.584

10.  Lung tissue mechanics and extracellular matrix remodeling in acute lung injury.

Authors:  P R Rocco; E M Negri; P M Kurtz; F P Vasconcellos; G H Silva; V L Capelozzi; P V Romero; W A Zin
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

View more
  2 in total

1.  IL-17A deficiency mitigates bleomycin-induced complement activation during lung fibrosis.

Authors:  Ellyse Cipolla; Amanda J Fisher; Hongmei Gu; Elizabeth A Mickler; Manisha Agarwal; Carol A Wilke; Kevin K Kim; Bethany B Moore; Ragini Vittal
Journal:  FASEB J       Date:  2017-08-17       Impact factor: 5.191

2.  Modeling pulmonary fibrosis by abnormal expression of telomerase/apoptosis/collagen V in experimental usual interstitial pneumonia.

Authors:  E R Parra; M S Pincelli; W R Teodoro; A P P Velosa; V Martins; M P Rangel; J V Barbas-Filho; V L Capelozzi
Journal:  Braz J Med Biol Res       Date:  2014-06-04       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.